General information

Acebilustat is a small-molecule drug under investigation. It is used in studies and not yet available as a human pharmaceutical. It is a leukotriene A4 hydrolase inhibitor with an effect on inflammation biomarkers. In relation to cystic fibrosis, our AIM tool found the data that acebilustat reduces both sputum and blood biomarkers related to inflammation in patients with cystic fibrosis.

Acebilustat on PubChem
Acebilustat on DrugBank

---

Synonyms

CTX-4430

---

Marketed as

N/A

---

Dietary sources

N/A